05/07/2024 6:15 AM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 3:30 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/28/2024 3:01 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 2:35 PM | ARMISTICE CAPITAL, LLC (Filed by) Eledon Pharmaceuticals, Inc. (Subject) Eledon Pharmaceuticals (Subject)
| Form SC 13G | |
11/09/2023 4:00 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/02/2023 4:51 PM | Eledon Pharmaceuticals, Inc. (Issuer) Eledon Pharmaceuticals (Issuer) Robinson James A. Jr. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/02/2023 4:08 PM | Eledon Pharmaceuticals, Inc. (Issuer) Eledon Pharmaceuticals (Issuer) Kirk Allan (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/02/2023 6:30 AM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2023 6:09 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 3:42 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 6:05 AM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2023 6:51 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2023 11:15 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form EFFECT | |
05/22/2023 12:26 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |